chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shingles happened to me after getting the shot/suspected vaccination failure; shingles broke out all around area of the shot miserable & painful; Painful; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: shingles happened to me after getting the shot/suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: shingles broke out all around area of the shot miserable & painful) and pain (Verbatim: Painful). The outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not reported.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 09-MAR-2023 This case was reported by a patient via interactive digital media. The reporter stated that the same thing happened to him/her after getting the shingles shot.  The shingles broke out all around the area of the shingles shot. They were miserable and painful. The reporter further stated that he/she sure did not want a full-blown case of shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The case had been linked to US2023AMR036639, reported in same post, for different patient The follow up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2023AMR036639:same reporter
1 day - dizzy and trembling 2 days - left arm very sore 3 days - left neck very stiff / sore 1 day - right heal pain 1 day - diarrhea, nausea, chills, fever, left facial numbness 2 day - hoarseness / throat inflammation menstrual cycle - 7 days early 1 day - left back muscle tightness / clenching - heart attack symptoms
patient stated 24-28 hours after vaccination she developed a rash with itching relieved by benadryl, that traveled from her neck down to her thigh area
Swelling at injection site; Redness at injection site; Rash at the injection site; Fatigue; Fast heart beat; Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE RASH (Rash at the injection site) and FATIGUE (Fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma. Concomitant products included FLUTICASONE PROPIONATE (FLOVENT) for Asthma.    On 02-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jul-2021, the patient experienced DIZZINESS (Dizzy), FATIGUE (Fatigue) and HEART RATE INCREASED (Fast heart beat). On 15-Jul-2021, the patient experienced VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE RASH (Rash at the injection site). At the time of the report, DIZZINESS (Dizzy), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE RASH (Rash at the injection site), FATIGUE (Fatigue) and HEART RATE INCREASED (Fast heart beat) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Jul-2021, Heart rate: increased (High) Had a fast heartbeat.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter said patient has not taken any medication for these symptoms.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sore throat on day 1 followed by congestion (cold) on day 2  & cough. No fever.
Three patients were administered a single dose of the Moderna COVID-19 vaccine from a vial that had been punctured and stored for greater than 12 hours.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Three patients were administered a single dose of the Moderna COVID-19 vaccine from a vial that had been punctured and stored for greater than 12 hours.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Three patients were administered a single dose of the Moderna COVID-19 vaccine from a vial that had been punctured and stored for greater than 12 hours.). On 31-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Three patients were administered a single dose of the Moderna COVID-19 vaccine from a vial that had been punctured and stored for greater than 12 hours.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.
Initially muscle pain at direct arm site was evident. Then followed by weakness and a need to sleep for 2 days. A fever on the 2nd day of 102. Also severe chills and almost convulsive body tremor occurred about 3 weeks after the initial Johnson 1x only vaccine adm 4/28/21. Following the booster shot given in early November 2021 blood lab tests  were given for continued fatigue.  Aged 55 female periods have returned  after both the initial vaccine for Covid, and then from since the booster given 3 weeks ago. The outcome of the blood lab was severe anemic bloodwork. 2nd blood lab  work has shown severe anemia and pending a lumbar puncture type biopsy to rule out  a rare blood cancer.
Information has been received from a nurse practitioner concerning a 24 year old patient of unknown gender, who on 23-MAR-2016 was inadvertently administered a dose of ZOSTAVAX (lot#, expiration date, dose and route unspecified) (inappropriate schedule of drug administration). No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
62yr old patient was ordered Pfizer booster vaccine on 10/7 during clinic visit.  Patient had previously received Pfizer COVID 19 vaccine (2/19/2021 and 3/6/2021).  CMA prepared and administered COVID-19 Moderna vaccine (LOT # 004C21A) on 10/7.  Only Pfizer COVID 19 vaccine has EUA approval for booster vaccine at this time.  MD notified.  Patient monitored 30min and discharged home in stable condition.  No patient harm noted.
Pain in arm at site. Fever.  Chills.  Muscle pain.  Headache.  Diarrhea. Sore throat.  Symptoms started appearing on day 1 and continuing on day 3 at time of this writing.   Treating my symptoms at home with Tylenol and drinking water.  9/3/21.
P/flu shot pt broke out in red blotchy rash started on arms, chest & entire body; approx 4 hrs later;
Redness and swelling on the back of my arm from shoulder to elbow. Hives on front of shoulder.  Itching. Pain and heat at injection site. Severe pain in arm - hurt to move it for 3 days. Pain subsided at beginning of 3rd day but redness and hives persist.
Myocarditis, presented with chest pain and syncope 3 days after second pfizer vaccination. Initial trop 3.3, peaked at 18. Currently hospitalized
Emergency room transfer to telemetry; admited from 3/7 to 3/18/21 with centralized Chest Pain that radiated to her right neck and shoulder, shortness of breath associated with the pain, loose stools - took baby aspirin.  Cardiology consulted: heart catheritization was performed and negative; Dischareged to home with AmLODIpine, aspirin, storvastatin, famotidine, imdur; follow up with PCP and cardiologist
Applied more than 1 dose to both patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (Applied more than 1 dose to both patients) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jul-2021, the patient experienced ACCIDENTAL OVERDOSE (Applied more than 1 dose to both patients). At the time of the report, ACCIDENTAL OVERDOSE (Applied more than 1 dose to both patients) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. The reporter stated that she used a wrong size syringe to apply the vaccine. No treatment information was provided.
administration of Pediarix to an 8y/o; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 8-year-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number 9X3T5, expiry date 5th March 2023) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 3rd August 2021, the patient received Pediarix and Pediarix Pre-Filled Syringe Device. On 3rd August 2021, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The health care professional reported that a 8 years old patient was administered Pediarix, which led to inappropriate age at vaccine administration. The reporter consented to follow up.
panic attacks; inflammation above the throat, arm and groin; tired eyes like patient has not slept; pain in the legs/sore arm; felt weak; body aches; tired; This spontaneous case was reported by a consumer and describes the occurrence of PANIC ATTACK (panic attacks), INFLAMMATION (inflammation above the throat, arm and groin), ASTHENOPIA (tired eyes like patient has not slept), PAIN IN EXTREMITY (pain in the legs/sore arm) and ASTHENIA (felt weak) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PANIC ATTACK (panic attacks), INFLAMMATION (inflammation above the throat, arm and groin), ASTHENOPIA (tired eyes like patient has not slept), PAIN IN EXTREMITY (pain in the legs/sore arm), ASTHENIA (felt weak), MYALGIA (body aches) and FATIGUE (tired). At the time of the report, PANIC ATTACK (panic attacks), INFLAMMATION (inflammation above the throat, arm and groin), ASTHENOPIA (tired eyes like patient has not slept), PAIN IN EXTREMITY (pain in the legs/sore arm), ASTHENIA (felt weak), MYALGIA (body aches) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Little bit tired; I'm a little sore; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of tiredness in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11-MAR-2023, the patient received the 2nd dose of Shingrix. On 11-MAR-2023, less than a day after receiving Shingrix, the patient experienced tiredness (Verbatim: Little bit tired) and pain (Verbatim: I'm a little sore). The outcome of the tiredness and pain were not recovered/not resolved.   It was unknown if the reporter considered the tiredness and pain to be related to Shingrix.     It was unknown if the company considered the tiredness and pain to be related to Shingrix.   Additional Information: GSK Receipt Date: 11-MAR-2023 This case was reported by the patient via interactive digital media.  He/she had his/her second Shingrix shot this morning on the day of reporting, he/she had a little soreness and was a little bit tired, but he/she had hoped that he/she never get shingles.  He/She would do whatever he/she could, to prevent the disease, and then he/she could just put his/her mind at rest. There was still a 9 percentile of chance of it (vaccine) not working and it was one thing he/she could put out of his/her mind, not that he/she thought that, he/she would never get shingles, but he/she had done whatever he/she could do to avoid it. Follow-up would not possible as no contact details were available.
This spontaneous report was received from physician refers to multiple unknown patients of unknown age and gender. The patients relevant medical history, concurrent conditions and concomitant medication were not reported. On an unknown date, the multiple unknown patients were vaccinated with PNEUMOVAX 23 injection (lot number/expiry date and dosage not reported). On an unknown dates, multiple unknown patients experienced unspecified (muscle aches) following the administration of PNEUMOVAX 23. The outcome of the event was unknown. The reporter did not provide any causality assessment between event and PNEUMOVAX 23. Additional information has been requested.
5 x 6 inch area of erythema and induration. Swelling and redness were gone by 5/5/13.
if she lifted both arms up she could tell which arm had the shot; muscle pain in upper arms and thighs; Chills; joint pain in hip and knee joints; This is a spontaneous report from a contactable consumer. A 76-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: not reported), via an unspecified route of administration on 08Feb2021 17:10 as DOSE 2, SINGLE for covid-19 immunisation (at the age of 76 years). Previously patient took first dose of Covid-19 vaccination in left arm on 15Jan2021 (Batch/lot number: EL8982; expiry date: May2021) for Covid-19 immunisation. Medical history included Diabetes , High cholesterol , visual impairment. Concomitant medications included atorvastatin 10 mg, 1x/day taken for blood cholesterol increased; metformin 500 mg, 2x/day orally taken for diabetes mellitus. History of all previous immunization with the Pfizer vaccine considered as suspect was none. The patient experienced muscle pain in upper arms and thighs, chills, joint pain in hip and knee joints on 12Mar2021; if she lifted both arms up she could tell which arm had the shot on an unspecified date. It was reported that Caller received her Pfizer Covid19 vaccination second shot on 08Feb2021 at 17:10. Caller stated she was experiencing muscle pain in both thighs and upper arms, chills and joint pain. Caller stated that the main one in muscle pain, it is hard to get up and down and hard to get in and out of the car. She stated these symptoms all started around 12Mar2021. The muscle pains are not equally troublesome all the time but it never disappears. The chills come and go. The joint pain is intermittent. Caller states that the muscle pain is the main/worst one, then the chills are second and the joint pain is third in severity. She started taking two Tylenol in the morning and at night, but she just started that about 3 days ago. She clarified that she was taking Acetaminophen, 500mg caplet, takes two caplets twice per day provided NDC: 69842-484-90, as well as a number that is beside the UPC-923789, and then directly under the UPC: 5042831899. Caller stated that if she lifted both arms up she could tell which arm had the shot, but that was all.   No follow-up attempts are possible: Information about lot/batch number cannot be obtained
Fever, Severe chills, aches, dizziness, fatigue, vomiting
Patient felt dizzy and sweating.  Patient put in semi fowlers position on a Saturday. VS T 97.7 degrees F, P 83, R18 B/P 11/72. Patient stated I feel much better 5 minutes post interventions. Stated I feel sleepy. Patient accompanied by her mother
sore throat and sinuses started started 4 days after injection, headache, fever, chills 5th and 6th day after injection.
Narrative: COVID infection following COVID vaccine series 01/16, Pfizer, dose #1 02/06, Pfizer, dose #2 10/26 COVID swab, result: detected 10/26 pt cc: exposure: unknown 10/30 clinically resolved
Just below injection site on my left arm - slight swelling, itching, redness (light) Second day it was slightly lower on arm and now, the third day, it is slightly over to the my right on left arm.
She contracted COVID-19 5 days after her first vaccination/She received the first vaccine on 19Feb2021, on 24Feb2021 she showed symptoms of COVID-19 and was diagnosed with a COVID-19 test; Swollen lung; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female received received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 via an unspecified route of administration on 19Feb2021 (Lot number was not reported) as single dose for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing.  The patient's concomitant medications were not reported.  The patient asked if she could receive her 2nd dose of the COVID-19 vaccine (Pfizer-BioNTech) if she contracted COVID-19 5 days after her first vaccination. She received the first vaccine on 19Feb2021, on 24Feb2021 she showed symptoms of COVID-19 and was diagnosed with a COVID-19 test. The patient stated that she was fine at the time of report, she didn't get pneumonia and didn't go to the hospital. She had a swollen lung, but she didn't have pneumonia. She has a history of asthma. Has not experienced fever for 15 days. Her blood oxygenation is 97 or 98% (24Feb2021). She asked if it is possible that receiving the 1st dose of the COVID-19 vaccine (Pfizer-BioNTech) contributed to showing only mild symptoms of COVID-19 and if the 2nd dose was not given 3 weeks after the first, is the COVID-19 vaccine (Pfizer-BioNTech) still effective. The patient recovered from the events.  Information about lot/batch number has been requested.
11 yo female with post vaccine- syncopal episode. Lasted 5-10 sec. No ill effect. Hx at similar syncope episode per father in past with administration of ear piercing. Neurosurgeon.
On 28FEB2023 symptoms were sore throat, runny nose, headache, body aches, chills. Temperature was ninety nine point five plus cough due to post nasal drip. 01MAR2023 I had a COVID-19 test, positive 02MAR2023 I had a virtual doctors on 03MAR2023 I started PAXLOVID by 07MAR2023 I felt much better and I had a relapse on 12MAR2023 and those symptoms lasted three days through 15MAR2023.
Patient is a 91 year old female who presented with a chief complaint of aphasia. Patient with increasing frequency in confusion episodes over the past few months. Patient presented in no acute distress, normal neurologic exam. Vitals stable, afebrile. Asymptomatic. CT Head without acute findings, but chronic microvascular disease consistent with age which may explain patient's symptoms. TIAs cannot be ruled out however at this time. Recommend patient be evaluated by neurology. Discussed with patient who is in agreement with plan.  Incidentally, patient with CXR findings consistent with pneumonia. Patient treated with antibiotics for CAP in case this is contributing to symptoms. COVID is positive but patient states that she tested positive in March and has received both vaccines. SpO2 94% on RA.
Chills led to nausea and the need to eliminate bowels. Lightheadedness, tunnel vision and rapid overheating occurred during the bowel movement (without straining) and resulted in fainting and loss of consciousness. Spouse was able to pick up and reawaken shortly thereafter, probably within 20 seconds, but unknown exactly how long. Water and acetaminophen were administered, and wet towels were applied to help cool body temperature which was hot to the touch. No fever to report when temperature was taken 5 minutes after the episode. Dizziness and lethargy have been present since the episode, going on 3 hours.
I went in for a routine mammogram, and when I got my results that doctor saw a spot on my imaging. I had a normal mammogram the year before so this was something new. I went in for a recheck 4-6 weeks later because the doctor said it could be a false positive due to recently having the COVID-19 vaccine. The spot still showed up on the image so they did a biopsy, and it came back as a B-Cell Lymphoma. I was not given any medications due to me not having any symptoms. I was told to come back for treatment if I start to experience symptoms.
This is a spontaneous report from a non-contactable consumer (patient).   A 29-year-old female patient received first dose and second dose od BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date unknown), both on an unspecified date at single dose via an unspecified route of administration  for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. On an unspecified date the patient experienced chills, pyrexia (99.8 degree temp) and pain. The patient recovered from the events on an unspecified date.  No follow-up attempts are possible. Information about lot/batch number cannot be requested. No further information is expected.